Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare News Netherlands.

uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy
LEXINGTON, Mass. and AMSTERDAM, Nov. 21, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the first patient has...

Healthcare Management Solution Market Massive Growth Opportunity Ahead | AMI Expeditionary Healthcare
According to HTF Market Intelligence, the Healthcare Management Solution market size is estimated to grow at a CAGR of 13.4% from 2024 to 2030. PUNE, MAHARASHTRA, INDIA, July 30, 2024 /EINPresswire.com/ -- HTF Market Intelligence recently...

Ignoring plastic health impact “delusional”, say leading health scientists
Scientists, NGOs like Plastic Soup Foundation, and insurers unite behind demands for robust UN Treaty during final negotiations New research finds financial valuation models fail to recognise the true risk of plastic pollution Leading health...

Clinical Oncology Next Generation Sequencing Market: A Comprehensive Study Exploring with Qiagen, Illumina, Perkin Elmer
Stay up-to-date with Clinical Oncology Next Generation Sequencing Market Size Analysis by Competitive landscape and Insights for next 5 years PUNE, MAHARASHTRA, INDIA, July 23, 2024 /EINPresswire.com/ -- HTF Market Intelligence recently released...

ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke
Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke Funding also supports technology development of ARC-BCI...

The Old Dutch Cupboard Explains the Benefits of Chicken for a Balanced Diet
TELFORD, PA, UNITED STATES, December 2, 2024 /EINPresswire.com/ -- Chicken has long been a staple in kitchens around the world due to its high protein content, affordability, and culinary flexibility. Now, The Old Dutch Cupboard encourages...

DEBx Medical Secures Expanded Investment from TVM Capital Healthcare
DEBx Medical is poised for accelerated growth in chronic wound solutions, bolstered by the second round of investment by TVM Capital Healthcare. AMSTERDAM and DUBAI, United Arab Emirates, Nov. 13, 2024 (GLOBE NEWSWIRE) -- DEBx Medical, an...

Healthcare BPO Services Market is Expected to See a Significant CAGR of 10.2%, To Reach a Value of $ 581.86 bn by 2030
Stay up-to-date with Global Healthcare BPO Services Market Research offered by HTF MI.Check how key trends and emerging drivers are shaping this industry growth PUNE, MAHARASHTRA, INDIA, July 24, 2024 /EINPresswire.com/ -- The latest study...

NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH
-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each of placebo, ezetimibe 10 mg, and obicetrapib 10 mg monotherapy at day 84 with statistical significance (p<0.001)...

Bicycle Market to Surpass USD 165.05 Billion by 2032 Owing to Growing Health Consciousness & Eco-Friendly Transportation
Bicycle Market is experiencing growth driven by the increasing demand for eco-friendly transportation, rising health awareness, & the expanding cycling culture AUSTIN, TX, UNITED STATES, November 19, 2024 /EINPresswire.com/ -- Bicycle Market The...

Khondrion receives FDA clearance of IND application for pivotal Phase 3 clinical trial of sonlicromanol for the treatment of primary mitochondrial disease
Khondrion receives FDA clearance of IND application for pivotal Phase 3 clinical trial of sonlicromanol for the treatment of primary mitochondrial disease 52-week Phase 3 trial to investigate potential of novel, brain-penetrant redox-modulator...

See hummingbirds up close at banding event in northeastern Utah
Dutch John — As hummingbirds are migrating through Utah this summer, you've most likely witnessed a few eating at a feeder or enjoying some other source of nectar for a quick meal. Join the Utah Division of Wildlife Resources, Ashley National...

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIA Potential for efgartigimod SC to be first targeted approach for...

Healthcare CMO Market Current Scenario and Future Prospects With Royal DSM, Recipharm AB
According to HTF Market Intelligence, the global Healthcare CMO market is estimated to grow with a CAGR of 15.01% from 2024 to 2030. PUNE, MAHARASHTRA, INDIA, July 20, 2024 /EINPresswire.com/ -- The Latest Market Research Study on “Global...
![[Latest] Global Cell and Gene Therapy Market Size/Share Worth USD 118.63 Billion by 2034 at a 18.79% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/images/pressrelease-small.png)
[Latest] Global Cell and Gene Therapy Market Size/Share Worth USD 118.63 Billion by 2034 at a 18.79% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Austin, TX, USA, June 25, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cell and Gene Therapy Market Size, Trends and Insights By Therapy Type (Cell Theray, Gene Therapy), By Therapeutic Class...

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer
ST. LOUIS, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that its ECLIPSE trial met its primary endpoint. ECLIPSE is a pivotal Phase 3, multi-center, open-label, randomized clinical trial comparing...

Europe Recyclable Packaging Market Starts from USD 7.17B in 2025 to USD 12.26B by 2034
Ottawa, July 11, 2025 (GLOBE NEWSWIRE) -- The global Europe recyclable packaging market size generated revenue of USD 7.17 Billion in 2025, and this figure is projected to grow to USD 12.26 Billion in 2034, according to research conducted by...

NewAmsterdam Pharma Presents Additional Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia at AHA Scientific Sessions 2024
– Met primary endpoint with LDL-C mean reduction versus placebo of 36.3% at day 84 and 41.5% at day 365 – – Lp(a) mean reduction versus placebo of 45.9% at day 84 and 54.3% at day 365 – – Total LDL-P mean reduction versus placebo of 52.5% at day...

ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights
EINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with...

The 2024 TITAN Health Awards Announces its Category Winners of the Year and Exceptional Winners of Season 2
The International Awards Associate (IAA), together with the TITAN Health Awards, proudly announces the 2024 winners for Season 2. NEW YORK, NY, UNITED STATES, November 8, 2024 /EINPresswire.com/ -- The International Awards Associate (IAA),...